Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Today Michigan.
Press releases published on September 3, 2025

AI Initiative Tackles Language Barriers for Arabic-Speaking Patients in Michigan
DEARBORN, MI, UNITED STATES, September 3, 2025 /EINPresswire.com/ -- Language barriers in health care put patients at risk of misdiagnoses, medication errors and inadequate treatment, with patients who have limited English proficiency facing …

AI Initiative Tackles Language Barriers for Arabic-Speaking Patients in Michigan
DEARBORN, MI, UNITED STATES, September 3, 2025 /EINPresswire.com/ -- Language barriers in health care put patients at risk of misdiagnoses, medication errors and inadequate treatment, with patients who have limited English proficiency facing …

Royal Weed Cannabis Dispensary Expands Services to Areas Beyond Paw Paw
New cannabis delivery service launched to serve neighboring communities in Southern Michigan. PAW PAW, MI, UNITED STATES, September 3, 2025 /EINPresswire.com/ -- Royal Weed Cannabis Dispensary has announced the expansion of its services to include …

HBox Names Dr. Rahul Chaudhary Chief Medical Officer To Drive Innovation At the Intersection of Clinical Care and AI
DETROIT, MI, UNITED STATES, September 3, 2025 /EINPresswire.com/ -- HBox today announced the appointment of Dr. Rahul Chaudhary, MD, as its new Chief Medical Officer (CMO), marking the culmination of a six-month search for a leader who embodies the …

Arcutis Submits Supplemental New Drug Application for ZORYVE® (roflumilast) Cream 0.3% to Expand Indication for Treatment of Plaque Psoriasis in Children Ages 2 to 5
If approved, ZORYVE cream would be the first and only topical PDE4 inhibitor indicated for plaque psoriasis in children as young as 2, offering patients and caregivers an important alternative to topical steroids and vitamin-D analogs ZORYVE cream is …

Artelo Biosciences Affirms Strong Partnering Outlook for ART27.13 Following Positive Interim Phase 2 CAReS Results
SOLANA BEACH, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic …

Clinical Asset Management leader TRIMEDX adds to leadership team with key technology hire to accelerate innovation and AI strategy
Indianapolis, Indiana, Sept. 03, 2025 (GLOBE NEWSWIRE) -- TRIMEDX—an industry-leading, independent clinical asset management company delivering comprehensive clinical engineering services, clinical asset informatics, and medical device cybersecurity—has …

Scenic Biotech Publishes Novel Drug Target for Mitochondrial and Cardiac Disease in Nature
Second Nature publication in 3 months highlights strength of Scenic’s proprietary Cell-Seq platform to identify modifier genes that positively influence disease severity Amsterdam, the Netherlands, September 03, 2025 – Scenic Biotech, a pioneer in the …

KFSHRC Reinforces Global Leadership as Early Adopter of Advanced cell and Gene Therapies
SAUDI ARABIA, Riyadh, Sept. 03, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital …

2025 Rising Stars to Take the Stage at BioNTX iC³® Life Science & Healthcare Innovation Summit
DALLAS, Sept. 03, 2025 (GLOBE NEWSWIRE) -- BioNTX has announced the 2025 Rising Stars, a select group of companies recognized for their bold contributions to life sciences and healthcare innovation. These trailblazing organizations will be formally …

Smith+Nephew extends Advanced Wound Bioactives portfolio with US launch of CENTRIO Platelet-Rich-Plasma System
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of the CENTRIO Platelet-Rich-Plasma (PRP) System, a biodynamic hematogel derived from a patient’s own platelets and plasma that, once applied, may assist the …

TeamACO reduces avoidable costs by $15.8M for Medicare value-based care program
KNOXVILLE, Tenn., Sept. 03, 2025 (GLOBE NEWSWIRE) -- In its inaugural year, TeamACO, TeamHealth’s accountable care organization, serving nearly 15,000 post-acute care patients in 33 states, is proud to announce it reduced avoidable costs of care for …

AMA Announces 2025 Joy in Medicine Recognized Health Organizations
CHICAGO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The American Medical Association (AMA) today named 109 hospitals, health systems and medical groups that have earned national distinction in 2025 as Joy in Medicine® organizations. The prestigious recognition …

Carbon Capture Made Scalable: Decarbontek Debuts Breakthrough Modular Adsorbent Technology
BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Massachusetts-based climate tech startup Decarbontek today announced a major breakthrough in carbon capture technology with the launch of its proprietary modular structured adsorbent platform, designed to …

MATTER Launches Major Initiative to Improve Health System in Ukraine
Minneapolis, MN, Sept. 03, 2025 (GLOBE NEWSWIRE) -- MATTER today announced a major initiative to strengthen the health system in Ukraine. This effort, involving a very challenging place in the world, implements diverse strategies by leveraging MATTER's …

BVI Unveils Virtuoso® – A Novel Dual-Function Surgical Platform for Cataract and Vitreoretinal Procedures
BVI announces Virtuoso®, its first dual-function phaco-vitrectomy system designed to deliver advanced control, efficiency, and versatility for both cataract and vitreoretinal surgery. European debut planned for 2025 Global ophthalmic congresses in Europe ( …

10 Surgeons Join USOSM Partner Practices in Eight States
IRVING, Texas, Sept. 03, 2025 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management (USOSM) is pleased to announce 10 additional oral and maxillofacial surgeons have joined partner practices in eight states – Texas, Washington, Kansas, Oregon, Massachusetts, …

Ernexa Therapeutics Announces Presentation At The H.C. Wainwright 27th Annual Global Investment Conference
CAMBRIDGE, Mass., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease, today announced it will be featured as a presenting …

PharmAla Incorporates Australian Entity for Clinical Research
TORONTO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its …

Dogwood Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference
ATLANTA, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), a development-stage biotechnology company developing new medicines to treat pain and fatigue-related disorders, today announces it will participate in …